gadolinium dtpa has been researched along with Hepatitis, Viral, Human in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbulut, S; Kahraman, AS; Kolu, M; Yildirim, IO | 1 |
| Kim, YK; Lee, JH; Lee, MH; Park, MJ | 1 |
2 other study(ies) available for gadolinium dtpa and Hepatitis, Viral, Human
| Article | Year |
|---|---|
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging-guided risk assessment in living donor liver transplant patients with postoperative complications: a pilot study.
Topics: Adult; Female; Gadolinium DTPA; Hepatitis, Viral, Human; Humans; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Prospective Studies; Risk Assessment | 2021 |
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chronic Disease; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Observer Variation; Sensitivity and Specificity | 2013 |